Search

Complete abstract information will be provided to the CMSC Annual Meeting attendees on May 28, 2023.

CMSC Abstracts Search Form (Titles and Authors only)

Search Accepted Abstracts
Sending

Search Results

Year ID Type Category Title Authors
2016 RH40 Poster Rehabilitation Research and Strategies

Effect of Fatigue on Sensory Impairment in Multiple Sclerosis

Stefanie DiCarrado, DPT, PT, CPT, CES, PES, Herbert I Karpatkin, PT, DSc, NCS, MSCS, Julia Karsten, SPT, Ashley McLoughlin, SPT, Melanie Rocchio, SPT and Christina Bianchi, SPT, Physical Therapy, Hunter College, New York, NY

2016 RH41 Poster Rehabilitation Research and Strategies

Oxygen Uptake Efficiency Slope Across the Disability Spectrum in Persons with Multiple Sclerosis

Thomas A Edwards, BKin1, Rachel E Klaren, BS1, Robert W Motl, PhD1 and Lara A Pilutti, PhD2, (1)Department of Kinesiology and Community Health, University of Illinois at Urbana Champaign, Urbana, IL, (2)Kinesiology and Community Health, University of Illinois at Urbana-Champaign, Urbana, IL

2016 RH42 Poster Rehabilitation Research and Strategies

Mscares: Therapy Protocol for Persons with Multiple Sclerosis

Tracy Flemming Tracy, OTR/L, MSCS, MSSMC1, Emily S Riser, MD2 and Danielle Lehman, OTS1, (1)Rehabilitation, Tanner Center for MS, Birmingham, AL, (2)Tanner Center for MS, Birmingham, AL

2016 RH43 Poster Rehabilitation Research and Strategies

Comparison of Actigraph, Fitbit and Manual Step Count during a Two-Minute Walk Test in People with Multiple Sclerosis: A Pilot Study

Valerie A J Block, PT DPTSc(c)1,2, Antoine Lizée, MSc1, Elizabeth Crabtree-Hartman, MD, MAS1, Carolyn J Bevan, MD1, Jennifer Graves, MD, PhD3, Ari J Green, MD4, Bardia Nourbakhsh, MD1, Matthew Tremblay, MD, PhD1, Gregory M Marcus, MD, MAS, FACC, FAHA, FHRS5, Jeffrey E Olgin, MD6, Mark Pletcher, MD, MPH7, Bruce AC Cree, MD, PhD8, Diane D Allen, PT, PhD9 and Jeffrey M Gelfand, MD, MAS1, (1)UCSF, San Francisco, CA, (2)Physical Therapy, San Francisco State University, San Francisco, CA, (3)UCSF Pediatric MS Center, San Francisco, CA, (4)Neurology, University of California, San Francisco, San Francisco, CA, (5)Director of Clinical Research, Division of Cardiology, UCSF, San Francisco, CA, (6)505 Parnassus Avenue Room M-1182A,, UCSF, San Francisco, CA, (7)University of California San Francisco Medical Center, San Francisco, CA, (8)University of California San Francisco, San Francisco, CA, (9)Graduate Program in Physical Therapy, University of California San Francisco/San Francisco State University, San Francisco, CA

2016 RH44 Poster Rehabilitation Research and Strategies

Physiotherapy and Walking Outcomes in Adults with Multiple Sclerosis: A Meta-Analysis

Yvonne C Learmonth, PhD, Ipek Ensari, EdM and Robert W Motl, PhD, Kinesiology and Community Health, University of Illinois at Urbana-Champaign, Urbana, IL

2016 SC01 Poster Basic Science

Blocking the Lipid Metabolism As a New Treatment Strategy for Multiple Sclerosis

Anne S. Mørkholt, PhD Student1, Soeren Nielsen, MD. Prof.2 and John D Nieland, PhD. Assoc. Prof.1, (1)Department of Health Science and Technologies, Aalborg University, Aalborg, Denmark, (2)Health Science and Technology, Aalborg University, Aalborg, Denmark

2016 SC02 Poster Basic Science

Effects of Disability on Lower Extremity Joint Contributions and Total Support Moment in Individuals with Multiple Sclerosis

Brandi Decoux, M.S.1, Lauren Brewer, M.Ed.1, Emily Riser, MD2 and Wei Liu, Ph.D.1, (1)School of Kinesiology, Auburn University, Auburn, AL, (2)Tanner Center and Foundation for Multiple Sclerosis, Birmingham, AL

2016 SC03 Poster Basic Science

T- and B-Lymphocyte Modulation Associated with Teriflunomide Treatment in Patients with Relapsing-Remitting MS: Analysis of the Phase 3b TERI-DYNAMIC Study

Heinz Wiendl, MD1, Catharina C Gross, PhD1, Maren Lindner, PhD1, Melanie Eschborn, MSc1, Linda Weisser, PhD1, Anita Posevitz-Fejfar, PhD1, Andreas Schulte-Mecklenbeck, PhD1, Bart Van Wijmeersch, MD, PhD2, Sandrine Brette, MSc3, Timothy J Turner, PhD4, Alexandre Jagerschmidt, PhD5, Amit Bar-Or, MD, FRCPC6, Raymond Hupperts, MD, PhD7 and Luisa Klotz, MD1, (1)University of Münster, Münster, Germany, (2)Hasselt University, Campus Diepenbeek, Hasselt, Belgium, (3)Lincoln, Boulogne-Billancourt, France, (4)Genzyme, a Sanofi company, Cambridge, MA, (5)Sanofi R&D, Chilly-Mazarin, France, (6)Montreal Neurological Institute, Montreal, QC, Canada, (7)School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands

2016 SC04 Poster Basic Science

Modeling Neural Progenitor Cell Dysfunction and Neurogenesis in a Stem Cell-Based Assay Model of Multiple Sclerosis

Jaime Imitola, MD, Laboratory for Neural Stem Cells and Functional Neurogenetics, Department of Neurology, Ohio State University, Columbus, OH, Michael K Racke, MD, The Ohio State University Wexner Medical Center, Columbus, OH and Fumihiro Watanabe, MD PhD, Ohio State University, Columbus, OH

2016 SC05 Poster Basic Science

Microbial Sequences in Multiple Sclerosis Brain Specimens

John D Kriesel, MD1, Preetida J Bhetariya, Ph.D.2, Cheryl Palmer, MD3, Kael F Fischer, Ph.D.3 and Alun Thomas, Ph.D.4, (1)Internal Medicine/Infectious Disease, University of Utah School of Medicine, Salt Lake City, UT, (2)Internal Medicine/Infectious Disease, University of Utah, Salt Lake City, UT, (3)Pathology, University of Utah School of Medicine, Salt Lake City, UT, (4)Genetic Epidemiology, University of Utah School of Medicine, Salt Lake City, UT

2016 SC06 Poster Basic Science

Dimethyl Fumarate Associated Lymphopenia Appears Driven by Selective CD8+ T Cell Depletion

Jong-Mi Lee, MSN – NP, Neuroscience, Stanford Healthcare, Stanford, CA and Jeffrey Dunn, MD, Neurology & Neurological Sciences, Stanford University Medical Center, Stanford, CA

2016 SC07 Poster Basic Science

Novel Biomarker of Balance Impairment in Minimally Impaired Individuals with MS

Kathleen L Roeing, BS, Douglas A Wajda, MS and Jacob J Sosnoff, PhD, Kinesiology and Community Health, University of Illinois at Urbana-Champaign, Urbana, IL

2016 SC08 Poster Basic Science

Assessing the Role of Citrullination and Lipid Interaction with Myelin Basic Protein in Multiple Sclerosis Etiology

Kenneth Kastaniegaard, MS1, Tue B Bennike, PhD1, Soeren Nielsen, MD. Prof.2, Allan Stensballe, PhD. Assoc. Prof.3 and John D Nieland, PhD. Assoc. Prof.3, (1)Department of Health Science and Technology, Aalborg University, Aalborg, Denmark, (2)Health Science and Technology, Aalborg University, Aalborg, Denmark, (3)Department of Health Science and Technologies, Aalborg University, Aalborg, Denmark

2016 SC09 Poster Basic Science

Changes in JC (John Cunningham) Virus Antibody Index in JC Positive Multiple Sclerosis (MS) Patients Treated with Natalizumab

Malcolm H Gottesman, MD1, Britany Klenofsky, MD2, Stephen Newman, MD3, Misu Paul, MD1, Rose Calixite, PhD1, Tiffany M Harding, CCRC, MSCS3 and Denise Grueneberg, RN1, (1)Neuroscience, Winthrop University Hosptial, Mineola, NY, (2)Medicine, Mt. Sinai Beth Isreal, NY, NY, (3)Island Neurological Associates, Plainview, NY

2016 SC10 Poster Basic Science

Effect of ACTH1-39 on the Oligodendroglial Differentiation Pathway with Regards to Myelin Membrane Sheet Formation

Andrew Kuo, M.S.E., Robert P. Lisak, M.D., Liljana Nedelkoska, B.S., Beverly Bealmear, B.A. and Joyce A Benjamins, Ph.D., Neurology, Wayne State University School of Medicine, Detroit, MI

2016 SC11 Poster Basic Science

Development of Neuromyelitis Optica Spectrum Disorder with Tumefactive Demyelination after Treatment with Monoclonal Anti-Tumor Necrosis Factor Alpha Antibodies

Thomas Shoemaker, MD, Neurology, University of Pittsburgh Medical Center, Pittsburgh, PA

2016 SX01 Poster Symptom Management

Dutch Guideline Adherence First-Line Injection Therapy Multiple Sclerosis

Astrid Slettenaar, MANP1, Monique Booy, MANP2, Lisette Trommelen, MANP3, Tiny Kempkens, MANP4, Kitty Harrison, MANP5, Klaas Arts, MD, neurologist6, Annette Baars, Master neurorevalidatie en innovatie7 and Leo Visser, Professor, PhD, MD, neurologist3, (1)MS-center Twente, Enschede, Netherlands, (2)Amphia Hospital, MS centre, BREDA, Netherlands, (3)MS-center Midden Brabant, Tilburg, Netherlands, (4)Zuyderland ziekenhuis, Sittard-Geleen, Netherlands, (5)Tergooi Ziekenhuis, Blaricum, Netherlands, (6)Winkler clinic, Pro Persona, Wolfheze, Netherlands, (7)Rijnstate ziekenhuis, Arnhem, Netherlands

2016 SX02 Poster Symptom Management

A Multicenter Randomized Controlled Trial Comparing Immediate and 6-Month Follow-up Effects of Two Group Programs on Fatigue and Self-Efficacy in People with MS

Cinda L Hugos, MS, PT1, Yiyi Chen, PhD2, Zunqiu Chen, MS2, Aaron P Turner, Ph.D. ABPP (RP)3, Jodie K Haselkorn, MD, MPH3, Toni Chiara, PhD, PT4, Sean McCoy, PhD4, Christopher Bever Jr., MD, MBA, FAAN5 and Dennis Bourdette, MD1,2, (1)VA Portland Health Care System, Portland, OR, (2)Oregon Health & Science University, Portland, OR, (3)Rehabilitation Care Service, VA Puget Sound Health Care System, Seattle, WA, (4)Malcom Randall VA Medical Center, Gainesville, FL, (5)VA Maryland Healthcare System, Baltimore, MD

2016 SX03 Poster Symptom Management

The Meaning of Physical Activity, Exercise and Sedentary Behavior in Persons with Multiple Sclerosis

Dominique L Kinnett-Hopkins, BS1, Robert W Motl, PhD2, Elizabeth A Hubbard, MSc2, Edward McAuley, PhD1, Lara A Pilutti, PhD2 and Yvonne C Learmonth, PhD2, (1)Department of Kinesiology and Community Health, University of Illinois at Urbana Champaign, Urbana, IL, (2)Kinesiology and Community Health, University of Illinois at Urbana-Champaign, Urbana, IL

2016 SX04 Poster Symptom Management

APS Therapy for Pain in People with MS: Report on a Two Year Pilot Study

Emma s Matthews, RN BSc Hons, MS CNS – Neurology, Northampton General Hospital, Northampton, United Kingdom of Great Britain and Northern Ireland and Miranda Olding, RGN MSCN, MS CNS, Beds & Northants MS Therapy Centre, Bedford, United Kingdom of Great Britain and Northern Ireland

2016 SX05 Poster Symptom Management

Clinical Efficacy of High Dose Biotin in the Treatment of Multiple Sclerosis

Mariah R. Francis, Registered Nurse, MSCN, Northwest Neurology, Lake Barrington, IL

2016 SX06 Poster Symptom Management

Real-World Comparison of Adherence and Persistence Among African-Americans with Multiple Sclerosis Treated with Fingolimod Versus Glatiramer Acetate

Mitzi J. Williams, MD1, Yujin Park, PharmD2, Kristen Johnson, PhD, MPH3, Rachel Halpern, PhD, MPH4, Helen Trenz, MA4, Stephanie Korrer, MPH4 and Vivian Herrera, DDS, MIA, MPH3, (1)Multiple Sclerosis Center of Atlanta, Atlanta, GA, (2)University of Maryland School of Pharmacy, Baltimore, MD, (3)Health Economics & Outcomes Research, Novartis Pharmaceuticals Corporation, East Hanover, NJ, (4)Health Economics and Outcomes Research, Optum, Eden Prairie, MN

2016 SX07 Poster Symptom Management

Real-World Comparison of Adherence and Persistence Between Hispanic Patients with Multiple Sclerosis Initiating Fingolimod or Glatiramer Acetate

Mitzi J. Williams, MD1, Yujin Park, PharmD2, Kristen Johnson, PhD, MPH3, Rachel Halpern, PhD, MPH4, Helen Trenz, MA4, Stephanie Korrer, MPH4 and Vivian Herrera, DDS, MIA, MPH3, (1)Multiple Sclerosis Center of Atlanta, Atlanta, GA, (2)University of Maryland School of Pharmacy, Baltimore, MD, (3)Health Economics & Outcomes Research, Novartis Pharmaceuticals Corporation, East Hanover, NJ, (4)Health Economics and Outcomes Research, Optum, Eden Prairie, MN

2016 SX08 Poster Symptom Management

Evaluation and Management of Functional Neurological Symptoms in Patients with Multiple Sclerosis

Naema Qureshi, MD and Laura T. Safar, MD, Psychiatry, Brigham and Women’s Hospital, Boston, MA

2016 SX09 Poster Symptom Management

Monitoring Fatigue with Mobile Phone Application- a Feasibility Study

Pamela K Newland, RN, PhD, CMSRN, Nursing, Barnes Jewish College, Goldfarb School of Nursing, St Louis, MO

2016 SX10 Poster Symptom Management

Using the Flinders Program to Develop a Self-Management Program for Patients with Fatigue

Rebecca M. Floyd, Ph.D. and Lara Stepleman, Ph.D., Georgia Regents University, Augusta, GA

2016 SX11 Poster Symptom Management

Relapse Management in Relapsing-Remitting Multiple Sclerosis (RRMS): Results from a Real-World Analysis of Treatment Patterns

Robert J Fox, MD, FAAN, Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH, David Templeton, MBA, Medical Data Analytics, Parsippany, NJ, Beth Lesher, PharmD, BCPS, Pharmerit International, Bethesda, MD and Manoj Malhotra, MD, Autoimmune and Rare Diseases, Mallinckrodt Pharmaceuticals, Hayward, CA

2016 SX12 Poster Symptom Management

Low Risk of New Flu-like Symptoms in Patients Transitioning from Non-Pegylated to Pegylated Interferon Beta-1a and Mitigation with Scheduled Naproxen

Robert T Naismith, MD1, Barry Hendin, M.D.2, Sibyl Wray, MD3, DeRen Huang, MD, PhD4, Phil You, PhD5 and Brian Werneburg, PhD5, (1)Neurology, Washington University School of Medicine, St Louis, MO, (2)Phoenix Neurological Associates, Phoenix, AZ, (3)Hope Neurology Multiple Sclerosis Center, Knoxville, TN, (4)Neurology and Neuroscience Associates, Akron, OH, (5)Biogen, Cambridge, MA

2016 SX13 Poster Symptom Management

Controversies in MS: Educational Intervention Improves Understanding of Key Concepts

Thomas Finnegan, PhD and John Maeglin, BA, Medscape LLC, New York, NY

2016 TC01 Poster Technology Advances

Initial Clinical Implementation of the Multiple Sclerosis Performance Test

Claire Hara-Cleaver, CNP, The Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH

2016 TC02 Poster Technology Advances

Betaconnect™ Autoinjector Comparator Market Research Study

Donald A Barone, D.O.1, Barry A Singer, MD2, Lubo Merkov, PhD3, Mark Rametta, D.O., FACOI, FACP4 and Gustavo Suarez, MD3, (1)University of Medicine and Dentistry of NJ School of Osteopathic Medicine, Stratford, NJ, (2)Missouri Baptist Medical Center, St. Louis, MO, (3)Bayer HealthCare Pharmaceuticals, Whippany, NJ, (4)US Medical Affairs, Neurology, Bayer HealthCare Pharmaceuticals, Whippany, NJ

2016 TC03 Poster Technology Advances

Project MS E.C.H.O – Outcomes of an Innovative Pilot to Improve Access to Care in Underserved Areas

Gary A Stobbe, MD1, Kevin N Alschuler, PhD2, Deborah P Hertz, MPH3, Annette Wundes, MD1, Gloria von Geldern, MD1, John D Scott, MD, MSc, FIDSA4, Kenton T Unruh, PhD4, Rosalind C Kalb, PhD3, Piper Reynolds, BA3, George H Kraft, MD2, Katharine Alexander, BA2 and Kurt Johnson, PhD2, (1)Neurology, University of Washington, Seattle, WA, (2)Department of Rehabilitation Medicine, University of Washington School of Medicine, Seattle, WA, (3)National Multiple Sclerosis Society, New York, NY, (4)Dept. of Medicine, University of Washington, Seattle, WA

2016 TC04 Poster Technology Advances

Connecting Healthcare Providers with Patients through Mobile Technology: Formula for Shared Decision Making and Improved Patient Outcomes

Elaine Rudell, CHCP1, Patty Peterson, CHCP1, Sandeep Pulim, MD1 and James D Bowen, MD2, (1)@Point of Care, Livingston, NJ, (2)Swedish Medical Center, Seattle, WA

2016 TC05 Poster Technology Advances

Accuracy and Precision of Smartphone Applications and Commercially Available Motion Sensors for Measuring Steps in Multiple Sclerosis

Julia M Balto, BSc1, Dominique L Kinnett-Hopkins, BS2 and Robert W Motl, PhD2, (1)Kinesiology and Community Health, University of Illinois at Urbana-Champaign, Urbana, IL, (2)Department of Kinesiology and Community Health, University of Illinois at Urbana Champaign, Urbana, IL

2016 TC06 Poster Technology Advances

Reducing Disparities in MS Care: An International Videoconference-Based Provider Education and Case Consultation Program

Kevin N Alschuler, PhD1,2, Annette Wundes, MD3, Dennis Dietrich, MD4, Bojan Boskovski, MD5, Igor Kuzmanovski, MD5, Gloria von Geldern, MD6, Katharine Alexander, BA2 and Gary Stobbe, MD6, (1)Neurology, University of Washington School of Medicine, Seattle, WA, (2)Department of Rehabilitation Medicine, University of Washington School of Medicine, Seattle, WA, (3)Rehabilitation Medicine, University of Washington, Seattle, WA, (4)Advanced Neurology Specialists, Great Falls, MT, (5)University Clinic for Neurology, Skopje, Macedonia, The former Yugoslav Republic of, (6)Neurology, University of Washington, Seattle, WA

2016 TC07 Poster Technology Advances

Development of a Smartphone Application for Children and Adolescents with Multiple Sclerosis and Their Parents

Lisa V Duffy, PhD, RN, Child Neurology, Boston Children’s Hospital, Boston, MA

2016 TC08 Poster Technology Advances

Impact of the Betaconnect Auto-Injector on Betaseron Therapy Adherence and Patient Satisfaction

Rebecca Germino, MA, US Health Economics and Outcomes Research, Bayer Healthcare Pharmaceuticals, Whippany, NJ and Mark Rametta, D.O., FACOI, FACP, US Medical Affairs, Neurology, Bayer HealthCare Pharmaceuticals, Whippany, NJ

2016 TC09 Poster Technology Advances

Creating a Closed-Chain Biomechanical Orthotic Environment for a 52 Year Old Female to Compete in a Para-Triathlon Using the Latest Carbon Composite Technology

Vincent DeCataldo, BOCPO, NJ LPO, Prosthetic and Orthotic, Allard USA, Rockaway, NJ

2016 TC10 Poster Technology Advances

Semi-Automated Optical Coherence Tomography in Clinical Practice

Zach Goodman, Undergraduate Student1, Samantha Lancia, MS1, Gautam Adusumilli, Undergraduate Student1, Courtney Dula, MS1, Paul Kealey, BS/BA2 and Robert T Naismith, MD1, (1)Department of Neurology, Division of Neuroimmunology, Washington University School of Medicine in St. Louis, St. Louis, MO, (2)Optovue, Incorporated, Freemont, CA